Robert T. Flynn

Results-driven pharmaceutical executive with 35+ years of experience leading business growth, manufacturing operations, and strategic planning within regulated pharmaceutical environments. Proven track record of increasing manufacturing capacity, securing key customer partnerships, driving profitability, and executing initiatives that strengthen enterprise value and support long-term growth objectives. Expertise in pharmaceutical manufacturing, aseptic processing, quality systems, and organizational leadership.

Chief Executive Officer - Sterling Pharmaceutical Services

(2020)

Responsible for overall corporate strategy, business growth, operations, customer development, and long-term value creation.

• Developed and executed a strategic growth plan that increased manufacturing capacity, expanded service offerings, and enhanced enterprise value in preparation for a future sale.
• Established a direct strategic partnership with Walgreens, successfully transitioning business previously managed through TRP to Sterling Pharmaceutical Services.
• Directed capital investments and aseptic facility modernization efforts that improved regulatory compliance, production capabilities, and operational efficiency.
• Implemented process improvements that increased production throughput, optimized resource utilization, and supported sustained revenue growth.
• Expanded customer relationships and business development initiatives, strengthening Sterling's market position and supporting scalable growth.

Vice President - Sterling Pharmaceutical Services

(2006 - 2020)

• Led all formulation and development activities for client projects and built five strategic partnerships that gave clients one-stop access to development services.
• Developed 12 new products (4 controlled release, 8 immediate release)
• Worked with clients developing alternate sourcing of materials reducing costs by $1,300,000 annually
• Developed intern program with local University
• Developed business development program which led to 90% increase in sales for company.

Director of Manufacturing - IMPAX Laboratories

(2003 - 2006)

Responsible for the management of all manufacturing activities, with 2 Managers, 9 supervisors and 132 associates. Responsible for a 9.5 million operating budget. Managed 6-million-dollar capital budget.

• Successfully supported launch of 18 ANDA products.
• Reduced documentation errors by 80%.
• Developed procedures and equipment for highly potent compounds.
• Implemented performance-based metric system.
• Developed team-based process improvement program.
• Developed and implemented operator training and qualification program.
• Successfully completed three FDA pre-approval inspections without a 483.

Plant Manager - KV Pharmaceutical

(2001 - 2003)

• Increased output from 1.1 million units to 1.6 million units monthly.
• Reduced backorder level from $7 million to zero.
• Successfully supported launch of 17 new products.
• Increased safety stock coverage from 31% to 93%.
• Increased bulk capacity by 38% without headcount increase.

Supervisor, Technical Training Support - KV Pharmaceutical

(2001 - 2001)

Assisted plant manager in day-to-day operations. Manufacturing liaison with Research and Development group. Supported technology transfer of R&D projects to production. Assisted plan supervisors with development and training programs to improve quality processes.

• Supported launch of 15 new products.
• Developed training matrix to increase cGMP compliance.
• Wrote 27 operational SOPs.
• Implemented a root cause analysis program for operational investigations.

Technical Support Advisor - SmithKline Beecham Worldwide Consumer Healthcare Company

(2000 - 2001)

Responsible for troubleshooting and coordinating repair of all manufacturing and packaging equipment. Write and implement all validation protocols for plant equipment. Train technical personnel on plant equipment. Help and support product investigation process. Identify and implement process improvements within the plant. Coordinate transfers of new product introductions into St. Louis facility liaising with internal staff and Research and Development group in New Jersey.

Weekend Manager / Pharmaceutical Manufacturing Supervisor - SmithKline Beecham Worldwide Consumer Healthcare Company

(1999 - 2000)

Manage the manufacturing department, which includes the added responsibilities of the weekend packaging and manufacturing operations. Responsible for a staff of 69 associates and 8 machinists with a budget of 5.75 million dollars.

• Hired a staff of 25 associates and 3 machinists, developed the weekend shift to increase production and decrease overtime.

Pharmaceutical Manufacturing Supervisor - SmithKline Beecham Worldwide Consumer Healthcare Company

(1996 - 1999)

Managed solid and liquid dosage manufacturing operations, maintenance, production planning, cGMP compliance, documentation systems, and personnel performance for a department of 44 associates and 5 machinists with a $4.15 million budget.

• Increased output by 11 million pounds while reducing headcount by nine associates. This represented a 32% increase over three years.
• Improved labor variance by $1,200,000 over 3 years.
• Highest single positive labor variance in department history $625,000 in 1997.
• Reduced cost of poor Quality by $300,000.
• Reduced overtime hours by 25%.
• Reduced documentation cost by $275,000.
• Implemented tablet press cleaning program and tooling inspection program that reduced tooling expenditures by $200,000 annually.
• Led a cross functional team that identified and eliminated a costly laminating problem in the tableting operations.

Pharmaceutical Packaging Supervisor - SmithKline Beecham Worldwide Consumer Healthcare Company

(1994 - 1996)

Led a tablet packaging team of 36 associates, managed the department's cGMP compliance program, and set the production schedule for all solid dosage packaged products. Responsible for all packaging-related investigations.

• Achieved a labor variance savings of $950,000.
• Improved labor efficiency by 22%.
• Progressively increased case output by 25% over 2-year period.
• Developed program allowing greater flexibility of all solid dosage bottle packaging lines, reducing changeovers by 60%.
• Streamlined and developed spreadsheets to reduce time needed for packaging reconciliations by 50%.

Pharmaceutical Manufacturing Group Leader - SmithKline Beecham Worldwide Consumer Healthcare Company

(1991 - 1994)

• Developed training program to integrate new associates.

Pharmaceutical Process Operator - SmithKline Beecham Worldwide Consumer Healthcare Company

(1989 - 1991)

Operated granulating, blending and tableting equipment under cGMP procedures.

Bachelor of Science Degree - Management, Minor in Human Resources - Maryville University